A weight loss drug repurposed to save lives

16 February 2021 by IdeaSpies

Healthcare

A weight-loss drug could be repurposed to prevent organ failure in patients in intensive care, research from the University of Auckland and Monash University in Australia shows.

Orlistat, marketed in New Zealand as Xenical, can be retooled to treat conditions such as severe acute pancreatitis, severe infection and haemorrhagic shock, according to the study published in the International Journal of Pharmaceutics.

Patent filed. Seeking commercial partners.

https://doi.org/10.1016/j.ijpharm.2021.120247

What do you think?

You must be logged in to post a comment.

Comments

mobiletestshanil @ 2021.02.18 3:06 AM

Good Idea

Related Posts

Healthcare

Kindness in health writing competition. Submissions due by 31 March 2024.

Acts of kindness happen every day in healthcare settings. Has a specific act of kindness stuck with you? Whether you work in hea

19 February 2024 by Jonathan Chri... 1 Comments

Healthcare

Exercise helps to prevent cancer

While any type of activity reduces risk, the significance of muscle mass in a cancer suppressing environment may make regular resi

19 February 2024 by IdeaSpies 0 Comments

Healthcare

Why are (too many) patients getting COVID in hospitals?

Too many patients are getting COVID in hospitals. These infections can be reduced with good Infection Prevention controls. Why is this not happening?Article by Hayley Gleeson (ABC):https://www.abc.net.au/news/2024-02-11/patients-catching-covid-hospitals-australia-infection-control/103442806?u

11 February 2024 by Jonathan Chri... 1 Comments

Why support us financially?

"Great ideas, research and innovation can come from anyone – so often the best ideas do not have a voice. IdeaSpies provides a platform for people to share ideas that create a better world"

Sharing Ideas that Do Good